Page last updated: 2024-08-26

droxidopa and homovanillic acid

droxidopa has been researched along with homovanillic acid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mizoguchi, K; Tanaka, M; Tsuda, A; Yokoo, H; Yoshida, M1
Ogawa, N; Ujike, H; Yamamoto, M1
Lakke, JP; Muskiet, FA; Staal-Schreinemachers, AL; Teelken, AW; van den Berg, GA; Wolthers, BG1
Edwards, DJ; Sedlock, ML1
Kondo, T1
Maruyama, W; Naoi, M; Narabayashi, H1

Reviews

1 review(s) available for droxidopa and homovanillic acid

ArticleYear
L-threo-DOPS in advanced parkinsonism.
    Advances in neurology, 1993, Volume: 60

    Topics: Brain; Cyclic AMP; Droxidopa; Homovanillic Acid; Humans; Neurologic Examination; Norepinephrine; Parkinson Disease

1993

Trials

1 trial(s) available for droxidopa and homovanillic acid

ArticleYear
The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
    Journal of the neurological sciences, 1996, Volume: 139, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antiparkinson Agents; Biogenic Monoamines; Cerebral Ventricles; Combined Modality Therapy; Dopamine; Droxidopa; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Middle Aged; Norepinephrine; Parkinson Disease; Reference Values; Stereotaxic Techniques; Thalamus

1996

Other Studies

4 other study(ies) available for droxidopa and homovanillic acid

ArticleYear
L-threo-3,4-dihydroxyphenylserine, a noradrenaline precursor, inhibits dopamine release and metabolism in the rat striatum in vivo.
    Experientia, 1992, Dec-01, Volume: 48, Issue:11-12

    Topics: Animals; Corpus Striatum; Dopamine; Droxidopa; Homovanillic Acid; Male; Rats; Rats, Wistar

1992
Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
    Clinical neuropharmacology, 1985, Volume: 8, Issue:4

    Topics: Droxidopa; Electromyography; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; MMPI; Movement Disorders; Serine

1985
Catecholamine metabolism during additional administration of DL-threo-3,4-dihydroxyphenylserine to patients with Parkinson's disease.
    Journal of neural transmission. Parkinson's disease and dementia section, 1989, Volume: 1, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Catecholamines; Dopamine; Droxidopa; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Parkinson Disease, Secondary; Serine

1989
Increased brain concentration of homovanillic acid in rats treated with threo-3,4-dihydroxyphenylserine.
    The Journal of pharmacy and pharmacology, 1982, Volume: 34, Issue:10

    Topics: Animals; Benserazide; Brain Chemistry; Droxidopa; Homovanillic Acid; Male; Norepinephrine; Phenylacetates; Rats; Rats, Inbred Strains; Serine

1982